Integrative Medicine in Pain Management in Sickle Cell Disease
NCT: NCT05045820 · ACTIVE_NOT_RECRUITING
NCT IDNCT05045820
StatusACTIVE_NOT_RECRUITING
Start Date2021-06-29
Completion2026-08-20
SponsorIndiana University (OTHER)
First posted
Last updated
Brief Summary
The proposed research is to determine the clinical efficacy and neurobiological mechanisms of acupuncture analgesia in patients with sickle cell disease.
Frequently Asked Questions
What is Integrative Medicine in Pain Management in Sickle Cell Disease?
Integrative Medicine in Pain Management in Sickle Cell Disease is a clinical trial registered under NCT05045820. Current status: ACTIVE_NOT_RECRUITING.
What is the status of NCT05045820?
The current status of NCT05045820 (Integrative Medicine in Pain Management in Sickle Cell Disease) is: ACTIVE_NOT_RECRUITING.
When did Integrative Medicine in Pain Management in Sickle Cell Disease start?
Integrative Medicine in Pain Management in Sickle Cell Disease started on 2021-06-29.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.